Spots Global Cancer Trial Database for Evaluation of a Topical Treatment for Actinic Keratosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of a Topical Treatment for Actinic Keratosis
Official Title: Phase 2 Double-blind, Randomized, Placebo-controlled, Parallel Group, Multi-center Study
Study ID: NCT01921907
Conditions
Study Description
Brief Summary: A topical treatment applied twice daily for 4 weeks to induce disappearance of facial actinic keratosis (AK). First 4 weeks treatment (visit 1, 2 and 3 at 0,2 an 4 weeks) treated as a double blind parallel study. From weeks 4 to 7 (visit 3 to visit 4) all patients to be treated by the active component.
Detailed Description:
Eligibility
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Maccabi Health Clinic, Tel Aviv, , Israel
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
